While GLP-1 RAs have been associated with GERD and esophageal complications such as erosive esophagitis and Barrett’s esophagus, retrospective cohort studies have also indicated that GLP-1 RAs may reduce the risk of esophageal cancer in patients with T2DM (6). This evidence concerns the gene GLP1R and Barrett esophagus.